JP Morgan Chase
LMAT icon

JP Morgan Chase’s LeMaitre Vascular LMAT Stock Holding History

JP Morgan Chase’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Buy
108,185
+28,698
+36% +$2.74M ﹤0.01% 2549
2025
Q4 		$6.45M Sell
79,487
-42,501
-35% -$3.66M ﹤0.01% 3088
2025
Q3 		$10.7M Sell
121,988
-27,800
-19% -$2.48M ﹤0.01% 2655
2025
Q2 		$12.4M Sell
149,788
-23,748
-14% -$1.98M ﹤0.01% 2357
2025
Q1 		$14.6M Buy
173,536
+26,047
+18% +$2.42M ﹤0.01% 2201
2024
Q4 		$13.6M Buy
147,489
+46,430
+46% +$4.47M ﹤0.01% 2408
2024
Q3 		$9.39M Sell
101,059
-27,324
-21% -$2.37M ﹤0.01% 2658
2024
Q2 		$10.6M Sell
128,383
-10,157
-7% -$746K ﹤0.01% 2415
2024
Q1 		$9.19M Sell
138,540
-23,843
-15% -$1.47M ﹤0.01% 2566
2023
Q4 		$9.22M Sell
162,383
-43,255
-21% -$2.27M ﹤0.01% 2566
2023
Q3 		$11.2M Sell
205,638
-9,158
-4% -$543K ﹤0.01% 2161
2023
Q2 		$14.5M Sell
214,796
-14,765
-6% -$901K ﹤0.01% 1973
2023
Q1 		$11.8M Buy
229,561
+13,297
+6% +$646K ﹤0.01% 2138
2022
Q4 		$9.95M Sell
216,264
-19,632
-8% -$919K ﹤0.01% 2255
2022
Q3 		$12M Buy
235,896
+716
+0.3% +$35.8K ﹤0.01% 2012
2022
Q2 		$10.7M Buy
235,180
+72,611
+45% +$3.25M ﹤0.01% 2100
2022
Q1 		$7.55M Sell
162,569
-24,097
-13% -$1.08M ﹤0.01% 2642
2021
Q4 		$9.38M Buy
186,666
+35,609
+24% +$1.84M ﹤0.01% 2509
2021
Q3 		$8.02M Buy
151,057
+4,129
+3% +$233K ﹤0.01% 2596
2021
Q2 		$8.96M Sell
146,928
-2,827
-2% -$150K ﹤0.01% 2523
2021
Q1 		$7.31M Buy
149,755
+36,369
+32% +$1.7M ﹤0.01% 2638
2020
Q4 		$4.59M Buy
113,386
+102,274
+920% +$3.66M ﹤0.01% 2881
2020
Q3 		$360K Buy
11,112
+1,081
+11% +$32.5K ﹤0.01% 4123
2020
Q2 		$265K Buy
10,031
+367
+4% +$9.59K ﹤0.01% 4142
2020
Q1 		$240K Sell
9,664
-17,474
-64% -$540K ﹤0.01% 4200
2019
Q4 		$975K Buy
27,138
+19,698
+265% +$680K ﹤0.01% 3880
2019
Q3 		$254K Buy
7,440
+2,225
+43% +$71.1K ﹤0.01% 4516
2019
Q2 		$145K Buy
5,215
+951
+22% +$26.4K ﹤0.01% 4785
2019
Q1 		$132K Buy
4,264
+185
+5% +$4.94K ﹤0.01% 4793
2018
Q4 		$96K Sell
4,079
-11,297
-73% -$309K ﹤0.01% 4868
2018
Q3 		$595K Buy
15,376
+4,020
+35% +$145K ﹤0.01% 4204
2018
Q2 		$380K Sell
11,356
-21,371
-65% -$760K ﹤0.01% 4295
2018
Q1 		$1.19M Buy
32,727
+8,102
+33% +$281K ﹤0.01% 3576
2017
Q4 		$784K Sell
24,625
-30,594
-55% -$1.05M ﹤0.01% 3855
2017
Q3 		$2.08M Sell
55,219
-760
-1% -$25.9K ﹤0.01% 3129
2017
Q2 		$1.75M Buy
55,979
+35,656
+175% +$1.03M ﹤0.01% 3134
2017
Q1 		$501K Sell
20,323
-50,618
-71% -$1.19M ﹤0.01% 3707
2016
Q4 		$1.8M Buy
70,941
+42,544
+150% +$944K ﹤0.01% 3133
2016
Q3 		$563K Buy
+28,397
New +$496K ﹤0.01% 3359

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase's LMAT Position: Q1 2026 in Review

JP Morgan Chase increased its LeMaitre Vascular (LMAT) stake by 36% in Q1 2026, buying an estimated $2.74M and bringing the position to 108,185 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

JP Morgan Chase first reported a position in LMAT in Q3 2016 and has held it in 39 quarters since. The position peaked at $14.6M in Q1 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • JP Morgan Chase held 108,185 shares of LeMaitre Vascular worth $11.6M as of Q1 2026.
  • JP Morgan Chase bought 28,698 LeMaitre Vascular shares in Q1 2026, an estimated $2.74M.
  • LeMaitre Vascular made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2549 holding.
  • JP Morgan Chase first reported a position in LeMaitre Vascular in Q3 2016 and has held it in 39 quarters since.
  • JP Morgan Chase's LeMaitre Vascular position peaked at $14.6M in Q1 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.